Study to Evaluate the Safety and Immunogenicity of a Lyophilized Herpes Zoster Virus mRNA Vaccine

NCT07400003 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

519

Enrollment

INDUSTRY

Sponsor class

Conditions

Herpes Zoster
mRNA Vaccine

Interventions

BIOLOGICAL: Low-dose experimental vaccine
BIOLOGICAL: High-dose experimental vaccine
BIOLOGICAL: Active-controlled vaccine A
BIOLOGICAL: Active-controlled vaccine B
OTHER: Placebo group

Sponsor

Sinovac Biotech Co., Ltd